The historic Serum Institute of India, the primary supplier of the COVAX distribution system for COVID-19 vaccines to underdeveloped countries, is cutting back their production of vaccines. Serum’s CEO Adar Poonawalla announced on India’s CNBC-TV18 on Dec. 8 that they are nearing fulfillment of their domestic orders for India, having provided almost 1.2 billion doses of their Covishield vaccine for jabs in India. And they have another 500 million doses in a stockpile. This comes close to enough jabs for the adult population of India. He said that he never thought he would be saying this, in the middle of a pandemic, but they are lacking orders for vaccines. As such, they are cutting back production of vaccines by 50% until orders pick up.
Related
Latest
